CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)
Clinical trials for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) trials appear
Sign up with your email to follow new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New treatment option opens for CIDP patients who have no other choices
Disease control AVAILABLEThis program provides efgartigimod PH20 SC to adults with CIDP who cannot join a clinical trial and have not gotten better with standard treatments like steroids or immunoglobulins. The goal is to offer a potential treatment option for those with active disease and unmet medical …
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)
Sponsor: argenx • Aim: Disease control
Last updated May 17, 2026 02:02 UTC
-
Experimental cell therapy targets tough autoimmune conditions
Disease control Recruiting nowThis early-stage study tests a new cell therapy called QH103 in 6 people with severe autoimmune diseases like multiple sclerosis and myasthenia gravis that haven't responded to standard treatments. The therapy uses specially engineered immune cells to target and calm the overacti…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Engineered immune cells take on multiple sclerosis and other autoimmune disorders
Disease control Recruiting nowThis early-phase study tests a new treatment called RD06-05, which uses specially engineered immune cells (CAR-T cells) to target and calm the overactive immune system in people with neurological autoimmune diseases like multiple sclerosis, myasthenia gravis, chronic inflammatory…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)
Phase: EARLY_PHASE1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated May 05, 2026 11:57 UTC
-
New nerve test could spot rare disease types faster
Knowledge-focused Recruiting nowThis study looks at how nerves send signals in people with Charcot-Marie-Tooth disease and other nerve disorders like CIDP. Researchers will use special electrical tests and ultrasound to measure nerve function and size. The goal is to find better ways to tell these conditions ap…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP)
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC